BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

FII Buying Spurs Market Optimism; Alembic Pharma, Newgen Software Signal Strong US Growth Prospects

FII Buying Spurs Market Optimism; Alembic Pharma, Newgen Software Signal Strong US Growth Prospects

Welcome to Markets Daily by Bajaj Broking, where we bring you the latest market insights to keep you ahead of the curve. Don’t forget to check out our Morning Podcast for more updates! 

Also Read: Stock Market Live Updates

FII Buying Spurs Market Optimism; Alembic Pharma, Newgen Software Signal Strong US Growth Prospects

Market Overview

Markets closed higher globally as investors digested the Federal Reserve's decision to hold rates steady amid rising inflation and unemployment concerns. US indices saw modest gains, led by consumer and tech stocks, while Asian markets responded positively to China’s stimulus hopes. Indian markets remained volatile but ended higher despite geopolitical tensions, with Nifty sustaining key support and showing bullish signs above moving averages.

Also Read: Prestige City Indirapuram Clocks Rs.3,000 Cr Sales in Just a Week

ALEMBIC PHARMACEUTICALS LTD.

Trade

902.155.30 (0.59 %)

Updated - 08 May 2025
906.70day high
DAY HIGH
885.60day low
DAY LOW
44029
VOLUME (BSE)

Key Levels & Outlook

The outlook suggests a range-bound trade, with strong support at 24,000–23,800 and resistance near 24,600. Derivative data points to cautious optimism, with FIIs turning slightly bullish and Bank Nifty showing potential for breakout moves.

Indian Markets

The Gift Nifty suggests a flat opening for Indian markets, which are expected to trade in the broad range of 23,800 - 24,550.

Previous Session (May 7th):

Indian benchmark indices ended higher, with Nifty closing just shy of the 24,400 level after a volatile session driven by escalating geopolitical risks. India’s strategic actions in the interest of national security continue, while the global sentiment remained cautious ahead of the U.S. Federal Reserve’s policy decision.

Sensex advanced 105.71 points (0.13%) to settle at 80,746.78.

Nifty gained 34.80 points (0.14%) to close at 24,414.40.

The BSE Midcap index outperformed, gaining 1.3%, while the Small-cap index advanced 1%.

On the sectoral front, indices like auto, media, realty, and consumer durables posted gains of around 1%, while FMCG and pharma were among the laggards.

Also Read: NLC India Signs MoU with IREL to Explore Critical Minerals Sector

Nifty Outlook (Short-Term)

Nifty formed a bullish candlestick pattern, indicating buying interest at lower levels around 24,200, supported by the index staying above its short-term and medium-term moving averages. The index is likely to remain range-bound between 24,600–24,000, with strong support at 24,000–23,800.

A sustained close above 24,550–24,600 could signal an upward move toward the December 2024 high of 24,850.

Intraday Levels:

Nifty Resistance: 24,490 & 24,600

Nifty Support: 24,300 & 24,220

Bank Nifty Resistance: 54,890 & 55,150

Bank Nifty Support: 54,330 & 54,100

Also Read: GMDC Signs 40-Year Limestone Supply Pact with City Gold Pipes

Global & Asian Market 

US Markets: Closed higher as investors processed the Fed's concerns about rising inflation and unemployment risks. The Dow gained 0.7%, the S&P 500 rose 0.4%, and the Nasdaq added 0.3%, led by consumer discretionary and tech stocks.

Asian Markets: Ended broadly higher despite early profit-taking. The uptick was driven by fresh stimulus measures from Beijing and positive talks between the U.S. and China.

Hong Kong’s Hang Seng rose 0.1%, while the Shanghai Composite gained 0.8%.

Other markets, including South Korea, Australia, Taiwan, and Southeast Asia, also posted gains.

Key Corporate News

Alembic Pharma expects continued growth in the US market, alongside margin improvements in its animal health segment.

Newgen Software targets sustained 20% growth, with US markets expected to drive future expansion.

FIIs net bought ₹2,585.86 crore, while DIIs net bought ₹2,378.49 crore in equities on May 7th (provisional).

Also Read: India UK FTA: 90% Tariff Lines Slashed, Export Boost Expected

Stay updated on market movements, and make informed decisions! Don’t forget to subscribe to our podcast.

Share this article: 

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text